Eimeldingen, Germany

Pascal Schmidt

This inventor holds 1 USPTO granted patent. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pascal Schmidt. Retrieved from https://idiyas.com/inventor/pascal-schmidt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Pascal Schmidt

Introduction

Pascal Schmidt is a notable inventor based in Eimeldingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of oligonucleotide research. His work has led to the development of innovative processes that enhance the efficiency of genetic research and applications.

Latest Patents

One of Pascal Schmidt's key patents is titled "Process for the Deprotection of Oligonucleotides." This patent addresses the challenges associated with the protection and deprotection of oligonucleotides, which are essential components in various biotechnological applications. With 1 patent to his name, Schmidt's work is recognized for its potential impact on the industry.

Career Highlights

Pascal Schmidt is currently employed at F. Hoffmann-La Roche AG, a leading global healthcare company. His role at Roche allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His expertise in oligonucleotide chemistry has positioned him as a valuable asset to the company.

Collaborations

Throughout his career, Schmidt has worked alongside talented colleagues, including Yong Rag Choi and Younggoo Kang. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Pascal Schmidt's contributions to biotechnology, particularly through his patent on oligonucleotide deprotection, highlight his role as an influential inventor. His work at F. Hoffmann-La Roche AG and collaborations with esteemed colleagues further emphasize his commitment to advancing scientific knowledge and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…